116 related articles for article (PubMed ID: 27989518)
1. Obesity and diabetes as prognostic factors in patients with colorectal cancer.
Voutsadakis IA
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S109-S114. PubMed ID: 27989518
[TBL] [Abstract][Full Text] [Related]
2. Diabetes, Obesity, and the Metabolic Syndrome as Prognostic Factors in Stages I to III Colorectal Cancer Patients.
Croft B; Reed M; Patrick C; Kovacevich N; Voutsadakis IA
J Gastrointest Cancer; 2019 Jun; 50(2):221-229. PubMed ID: 29335847
[TBL] [Abstract][Full Text] [Related]
3. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
4. The effects of obesity and obesity-related conditions on colorectal cancer prognosis.
Siegel EM; Ulrich CM; Poole EM; Holmes RS; Jacobsen PB; Shibata D
Cancer Control; 2010 Jan; 17(1):52-7. PubMed ID: 20010519
[TBL] [Abstract][Full Text] [Related]
5. Association Among Obesity, Metabolic Health, and the Risk for Colorectal Cancer in the General Population in Korea Using the National Health Insurance Service-National Sample Cohort.
Shin CM; Han K; Lee DH; Choi YJ; Kim N; Park YS; Yoon H
Dis Colon Rectum; 2017 Nov; 60(11):1192-1200. PubMed ID: 28991084
[TBL] [Abstract][Full Text] [Related]
6. Effect of physical activity and body size on survival after diagnosis with colorectal cancer.
Haydon AM; Macinnis RJ; English DR; Giles GG
Gut; 2006 Jan; 55(1):62-7. PubMed ID: 15972299
[TBL] [Abstract][Full Text] [Related]
7. Correlations between obesity/metabolic syndrome-related factors and risk of developing colorectal tumors.
Harima S; Hashimoto S; Shibata H; Matsunaga T; Tanabe R; Terai S; Sakaida I
Hepatogastroenterology; 2013 Jun; 60(124):733-7. PubMed ID: 23165194
[TBL] [Abstract][Full Text] [Related]
8. New Horizons: Epidemiology of Obesity, Diabetes Mellitus, and Cancer Prognosis.
Harborg S; Kjærgaard KA; Thomsen RW; Borgquist S; Cronin-Fenton D; Hjorth CF
J Clin Endocrinol Metab; 2024 Mar; 109(4):924-935. PubMed ID: 37552777
[TBL] [Abstract][Full Text] [Related]
9. Association of liver steatosis with colorectal cancer and adenoma in patients with metabolic syndrome.
Fiori E; Lamazza A; De Masi E; Schillaci A; Crocetti D; Antoniozzi A; Sterpetti AV; De Toma G
Anticancer Res; 2015 Apr; 35(4):2211-4. PubMed ID: 25862880
[TBL] [Abstract][Full Text] [Related]
10. [The colorectal carcinoma risk factors].
Sobczak A; Wawrzyn-Sobczak K; Sobaniec-Lotowska M
Pol Merkur Lekarski; 2005 Dec; 19(114):808-11. PubMed ID: 16521429
[TBL] [Abstract][Full Text] [Related]
11. Visceral Adiposity is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant Chemotherapy.
Lee CS; Murphy DJ; McMahon C; Nolan B; Cullen G; Mulcahy H; Sheahan K; Barnes E; Fennelly D; Ryan EJ; Doherty GA
J Gastrointest Cancer; 2015 Sep; 46(3):243-50. PubMed ID: 25832480
[TBL] [Abstract][Full Text] [Related]
12. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Phenotype and Risk of Colorectal Cancer in Normal-Weight Postmenopausal Women.
Liang X; Margolis KL; Hendryx M; Rohan TE; Groessl EJ; Thomson CA; Kroenke CH; Simon MS; Lane D; Stefanick M; Luo J
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):155-161. PubMed ID: 28148595
[TBL] [Abstract][Full Text] [Related]
14. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study.
Stürmer T; Buring JE; Lee IM; Gaziano JM; Glynn RJ
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2391-7. PubMed ID: 17164361
[TBL] [Abstract][Full Text] [Related]
15. Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases.
Amptoulach S; Gross G; Kalaitzakis E
J Surg Res; 2015 Dec; 199(2):378-85. PubMed ID: 26115811
[TBL] [Abstract][Full Text] [Related]
16. [Impact of number of retrieved lymph nodes and lymph node ratio on the prognosis in patients with stage II and III colorectal cancer].
Shao XL; Han HQ; He XL; Fu Q; Lv YC; Liu G
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Apr; 14(4):249-53. PubMed ID: 21538264
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy.
Ottaiano A; Nappi A; Tafuto S; Nasti G; De Divitiis C; Romano C; Cassata A; Casaretti R; Silvestro L; Avallone A; Capuozzo M; Capozzi M; Maiolino P; Quagliariello V; Scala S; Iaffaioli VR
Oncology; 2016; 90(1):36-42. PubMed ID: 26731722
[TBL] [Abstract][Full Text] [Related]
18. Obesity and colorectal cancer.
Bardou M; Barkun AN; Martel M
Gut; 2013 Jun; 62(6):933-47. PubMed ID: 23481261
[TBL] [Abstract][Full Text] [Related]
19. [New prognostic markers in colorectal cancer].
Nielsen HJ; Brünner NA; Thorlacius-Ussing O; Kehlet H
Ugeskr Laeger; 1998 Aug; 160(32):4617-21. PubMed ID: 9719740
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions.
Kato T; Yasui K; Hirai T; Kanemitsu Y; Mori T; Sugihara K; Mochizuki H; Yamamoto J
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S22-31. PubMed ID: 14530655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
